Literature DB >> 24987319

Management of coagulopathy in liver disease.

Stephen H Caldwell1.   

Abstract

Entities:  

Year:  2014        PMID： 24987319      PMCID： PMC4076882     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?

Authors:  Neeral L Shah; Stephen H Caldwell; Carl L Berg
Journal:  Clin Liver Dis       Date:  2009-02       Impact factor: 6.126

Review 2.  The coagulopathy of chronic liver disease.

Authors:  Armando Tripodi; Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

3.  Hemostasis and thrombosis in patients with liver disease: the ups and downs.

Authors:  Ton Lisman; Stephen H Caldwell; Andrew K Burroughs; Patrick G Northup; Marco Senzolo; R Todd Stravitz; Armando Tripodi; James F Trotter; Dominique-Charles Valla; Robert J Porte
Journal:  J Hepatol       Date:  2010-05-12       Impact factor: 25.083

4.  Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial.

Authors:  Carmen M Stanca; Andre H Montazem; Adeyemi Lawal; Jin X Zhang; Thomas D Schiano
Journal:  J Oral Maxillofac Surg       Date:  2010-01       Impact factor: 1.895

Review 5.  Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.

Authors:  Francesco Violi; Domenico Ferro
Journal:  Semin Thromb Hemost       Date:  2013-03-13       Impact factor: 4.180

Review 6.  Coagulation in liver disease: a guide for the clinician.

Authors:  Patrick G Northup; Stephen H Caldwell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-16       Impact factor: 11.382
  6 in total
  1 in total

1.  Effect of FFP Transfusion on International Normalized Ratio in Liver Disease Patients.

Authors:  Sukanya Baruah; Meenu Bajpai
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-03       Impact factor: 0.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.